AWilson disease maintenance therapy
First line
Wilson disease maintenance therapy
First line
Zinc acetate (Wilzin, Galzin) or zinc sulphate is maintenance therapy for Wilson disease after the initial copper chelation phase. Dose: 50 mg elemental zinc three times daily. Included in 2012 and 2023 guidelines as maintenance therapy. In asymptomatic ATP7B mutation carriers, it is first-line therapy. The effect develops over 4–8 weeks and requires lifelong use.
Used in specialised hepatology centres; not for self-prescription.
Sources
ICD-10: E83.0 · ICD-11: 5C64.00